Use of polydextrose for simulating the functional attributes of human milk oligosaccharides in formula-fed infants
CA 2815780 C · Owner: Mjn U.S. Holdings Llc · Inventors: Gibson, Glenn R.; Rastall, Robert A.; Aura, Anna-Marja
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention is directed to a novel use of PDX in the manufacture of a medicament for increasing the production of acetate decreasing the production of butyrate, increasing the population and species of beneficial bacterial and slowing the rate of fermentation of prebiotics within the gut of a formula-fed infant.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed March 23, 2006 and granted February 13, 2018. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended March 23, 2026.
- Certificates of supplementary protection extend only drug patents, and it isn't classified as one.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.